6 completed, 2 unknown. 8 Phase 1, 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 8 | Completed 6, Unknown 2 |
| Phase 2 | 4 | Completed 3, Unknown 1 |
Follow estramustine phosphate sodium: new trials by email Literature Review of estramustine phosphate sodium trials Research Report on estramustine phosphate sodium
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Ixabepilone With or Without Estramustine in Treating Patients With Progressive Prostate Cancer estramustine phosphate sodium, ixabepilone - Prostate Cancer | Phase 1 / Phase 2 | Completed | Memorial Sloan Kettering Cancer Center | 2001-07-01 | 2013-06-24 | |
| Estramustine, Docetaxel, and Carboplatin in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy carboplatin, docetaxel, estramustine phosphate sodium - Prostate Cancer | Phase 1 | Completed | Dana-Farber Cancer Institute | 1999-03-01 | 2013-07-18 | |
| Combination Chemotherapy in Treating Patients With Advanced Cancer estramustine phosphate sodium, paclitaxel, vinorelbine ditartrate - Leukemia, Lymphoma | Phase 1 / Phase 2 | Completed | NYU Langone Health | 1998-09-01 | 2011-03-28 | |
| Combination Chemotherapy in Treating Patients With Advanced Prostate Cancer docetaxel, estramustine phosphate sodium, mitoxantrone hydrochloride - Prostate Cancer | Phase 1 | Unknown | Herbert Irving Comprehensive Cancer Center | 12 | 1998-08-01 | 2013-12-19 |
| Combination Chemotherapy in Treating Patients With Advanced Prostate Cancer carboplatin, endocrine-modulating drug therapy, estramustine phosphate sodium - Prostate Cancer | Phase 1 / Phase 2 | Completed | Memorial Sloan Kettering Cancer Center | 18 | 1998-04-01 | 2013-06-24 |
| Docetaxel Plus Estramustine in Treating Patients With Metastatic Prostate Cancer docetaxel, estramustine phosphate sodium - Prostate Cancer | Phase 1 / Phase 2 | Unknown | Herbert Irving Comprehensive Cancer Center | 37 | 1998-02-01 | 2014-01-06 |
| Estramustine and Paclitaxel in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy estramustine phosphate sodium, paclitaxel - Prostate Cancer | Phase 1 | Completed | NYU Langone Health | 1997-04-01 | 2012-11-09 | |
| Doxorubicin Plus Estramustine in Treating Patients With Metastatic Prostate Cancer doxorubicin hydrochloride, estramustine phosphate sodium, drug resistance inhibition treatment - Prostate Cancer | Phase 1 | Completed | University of New Mexico | 18 | 1995-03-01 | 2014-05-21 |
Prostatic Neoplasms (7) · Burkitt Lymphoma (1) · Fibrosarcoma (1) · Hodgkin Disease (1) · Leukemia (1) · Leukemia, Lymphocytic, Chronic, B-Cell (1) · Leukemia, Myeloid, Acute (1) · Lymphoma (1) · Lymphoma, B-Cell, Marginal Zone (1) · Lymphoma, Follicular (1) · Lymphoma, Large B-Cell, Diffuse (1) · Lymphoma, Large-Cell, Immunoblastic (1) · Lymphoma, Mantle-Cell (1) · Lymphoma, Non-Hodgkin (1) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (1)
Herbert Irving Comprehensive Cancer Center (2) · Memorial Sloan Kettering Cancer Center (2) · NYU Langone Health (2) · Dana-Farber Cancer Institute (1) · University of New Mexico (1)
United States (8)
Daniel P. Petrylak, MD (2) · Abraham Chachoua, MD (1) · Anthony Y. Smith, MD (1) · Franco M. Muggia, MD (1) · Michael Morris, MD (1) · William K. Kelly, DO (1) · William Oh, MD (1)
PMID 14504052, PMID 15671557, PMID 15735119
P30CA016087 (1)